about
Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of IvabradineThe ryanodine receptor leak: how a tattered receptor plunges the failing heart into crisisHeart Failure: Diagnosis, Severity Estimation and Prediction of Adverse Events Through Machine Learning Techniques.Higher education is associated with reduced risk of heart failure among patients with acute myocardial infarction: A nationwide analysis using data from the CVDNOR project.Clinical effectiveness, access to, and satisfaction with care using a telehomecare substitution intervention: a randomized controlled trial.A qualitative study of the current state of heart failure community care in Canada: what can we learn for the future?Registered Nurses' Perceptions about the Situation of Family Caregivers to Patients with Heart Failure - A Focus Group Interview StudyThe Relationship between Perceived Life Changes and Mental Health in Family Caregivers of Patients with Heart Failure who Referred to Rajaei Cardiovascular Medical and Research Center, Tehran.Initial In Vivo Evaluation of a Novel Left Ventricular Assist DevicePerturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.Precipitant profile of acute heart failure: experience of a tertiary level cardiac centre in Sri Lanka.Multi-state modelling of repeated hospitalisation and death in patients with heart failure: The use of large administrative databases in clinical epidemiology.Patients with heart failure have an increased risk of incident cancer.Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.The Role of Computed Tomography in Predicting Left Ventricular Assist Device Infectious Complications.Rethinking Heart Failure.Thyroid hormone and cardiac repair/regeneration: from Prometheus myth to reality?Renal replacement therapy in congestive heart failure requiring left ventricular assist device augmentationComparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective.Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.Circulating endothelial-derived apoptotic microparticles in the patients with ischemic symptomatic chronic heart failure: relevance of pro-inflammatory activation and outcomes.The changing face of heart failure: are we really making progress?The Evolution of mHealth Solutions for Heart Failure Management.Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease.Socioeconomic Inequalities in Health and Perceived Unmet Needs for Healthcare among the Elderly in Germany.Heat Failure Phenotypes Induced by Knockdown of DAPIT in Zebrafish: A New Insight into Mechanism of Dilated Cardiomyopathy.The influence of aetiology on the benefits of exercise training in patients with heart failure.State-of-the-Art in Tissue-Engineered Heart RepairQualitative study of challenges of caring for a person with heart failure.Patients with a Left Ventricular Assist Device: the new chronic patient in cardiology
P2860
Q26773370-D013DD92-F22B-4EA3-9F65-6FB6B9F58146Q26861625-5DF5014C-8213-41C2-84E2-EEDB2D8F00ECQ28075346-53E1939F-0F0A-48F2-8E00-8A78F9097E22Q31115853-71E075A5-9F6E-49F4-9DA7-54D254ED5E84Q35609064-D97DAE59-01C4-496F-AE66-8FCC27C8E5EAQ35717686-2B968144-F72F-4F45-839C-4F31BB3D3EB1Q36098937-3D5D8330-1B0D-44C1-85E3-C2FA5F592F16Q36114943-B9C6EEDD-516E-44E5-912F-CF56A6BAC3B1Q36204026-0AB99757-1D8C-4A6A-9974-A5F7D0F303E7Q36605039-D80D7A57-08A2-4263-858D-988DDAF405CDQ36800830-26487E23-B89F-41B2-8528-A35A38959575Q37135705-7328743F-EFC4-4859-81B2-C9815EABBB24Q37136235-9728B8A2-AECE-45F8-9AB7-9E64A21A0C76Q37166899-B67E8A35-C60B-4256-8389-38BDA0EB1918Q37390595-50BBC194-1523-4BD0-9F0D-EC30B3759BFBQ37711505-FED0B9DB-2C2A-4BEF-83D7-6D4DF45F7235Q38023872-B15CC254-6ED6-411A-A7A0-4BE2376833D8Q38031828-8C2D1159-E50E-4234-90C9-52BB503F7996Q38042554-DD42C53E-6524-48B3-92AB-F703C9146CAAQ38100223-AD8523FA-9E0F-426A-BCEF-8837F47D2838Q42745980-768F3139-6D05-47A1-8332-58FAE473926BQ45819043-CF08F379-75E2-4264-B37A-209252DF73A5Q46294395-64A88558-8EE1-4050-B9BB-599410BF5DCDQ46913426-0B4A170A-A6F3-47A8-B83D-4B7362D3DCBDQ47095996-0DE4ED57-A87E-43D8-B44D-D2B9C29835CAQ47152288-1BF99139-838F-4276-9489-C4641ACED9FFQ47606451-36331443-053F-4F2C-A159-F34E4E816485Q48774892-D41EC98E-4040-4BAA-9B37-D3B98DE6CB4CQ49919562-EFE07E93-6FB8-45F9-8D33-5EAD6C59008DQ57315229-C059B6B6-06A0-4F69-A14A-5A4A1F45E27F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The heart failure epidemic.
@ast
The heart failure epidemic.
@en
type
label
The heart failure epidemic.
@ast
The heart failure epidemic.
@en
prefLabel
The heart failure epidemic.
@ast
The heart failure epidemic.
@en
P2860
P356
P1476
The heart failure epidemic.
@en
P2093
Véronique L Roger
P2860
P304
P356
10.3390/IJERPH7041807
P5008
P577
2010-04-01T00:00:00Z
2010-04-19T00:00:00Z